---
$id: https://graph.org.ai/products/commodity/51281657
$type: Product
source: UNSPSC
code: "51281657"
title: "Neomycin c"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neomycin c

**UNSPSC Code**: 51281657
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6B1U1NS16Z, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as neomycin c, which bears US NIH Compound Identifier 4454. European Medicines Agency schedules neomycin c or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG. Most nations, for tariff purposes, schedule neomycin c under HS 29419000. Neomycin c bears US NLM identifiers UMLS ID C0068521 and NCI Concept Code C95127. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CN)O)O)N)O)O)N.

